Tsukuba, Japan

Masashiro Iwata

This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masashiro Iwata. Retrieved from https://idiyas.com/inventor/masashiro-iwata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masashiro Iwata: Innovator in Respiratory Disease Treatment

Introduction

Masashiro Iwata is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating respiratory diseases. His work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

Iwata holds a patent for a compound known as Diaminopyrimidinecarboxamide derivative. This compound is designed for the prevention or treatment of respiratory diseases, specifically those involving STAT 6, such as asthma and chronic obstructive pulmonary disease. The patent details a pyrimidine derivative or a salt thereof, which features an arylamino or arylethylamino group at the 2-position, an amino group substituted with a benzyl group at the 4-position, and a carbamoyl group at the 5-position.

Career Highlights

Iwata is currently associated with Astellas Pharma GmbH, where he continues to contribute to pharmaceutical innovations. His expertise in medicinal chemistry and drug development has positioned him as a key figure in his field.

Collaborations

Some of his notable coworkers include Shinya Nagashima and Hiroshi Nagata. Their collaborative efforts have further advanced the research and development of effective treatments for respiratory conditions.

Conclusion

Masashiro Iwata's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions to respiratory disease treatment highlight the importance of research and development in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…